Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Published:2021-09 Issue: Volume:22 Page:172-182
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Awad Robin Maximilian,Lecocq Quentin,Zeven Katty,Ertveldt Thomas,De Beck Lien,Ceuppens Hannelore,Broos Katrijn,De Vlaeminck Yannick,Goyvaerts Cleo,Verdonck Magali,Raes Geert,Van Parys Alexander,Cauwels Anje,Keyaerts Marleen,Devoogdt Nick,Breckpot Karine

Funder

IWT

Stichting Tegen Kanker

Melanoma Research Alliance

Research Foundation Flanders

Kom op tegen kanker

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference45 articles.

1. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates;Brahmer;J. Clin. Oncol.,2010

2. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N. Engl. J. Med.,2012

3. A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer;Rimm;JAMA Oncol.,2017

4. Use of immunotherapy with programmed cell death 1 vs programmed cell death ligand 1 inhibitors in patients with cancer: A systematic review and meta-analysis;Duan;JAMA Oncol.,2020

5. Survival, durable response, and long-term safety in patients with previously treated advanced renal cell carcinoma receiving nivolumab;McDermott;J. Clin. Oncol.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sustained release of a human PD-L1 single-domain antibody using peptide-based hydrogels;European Journal of Pharmaceutics and Biopharmaceutics;2024-03

2. Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management;Cancers;2024-01-15

3. Novel technologies for applying immune checkpoint blockers;International Review of Cell and Molecular Biology;2024

4. In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells;Scientific Reports;2023-11-03

5. Shark IgNAR: The Next Broad Application Antibody in Clinical Diagnoses and Tumor Therapies?;Marine Drugs;2023-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3